Loading...
DDIS-25. PENTAMIDINE; A NEW CHEMOTHERAPY TARGETING ON GLIOMA STEM LIKE CELLS
INTRODUCTION: Glioblastoma (GBM) is the most common primary malignant brain tumors. Despite aggressive therapies, median overall survival of patients who suffered from GBM is only 18 months. Furthermore, there is no effective therapy for glioma stem cells (GSCs), which act as forming tumors. Herein,...
Na minha lista:
| Udgivet i: | Neuro Oncol |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6847863/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.276 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|